Chimerix: Q4 Earnings Snapshot

March 1, 2022 GMT

DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Tuesday reported a loss of $39.5 million in its fourth quarter.

The Durham, North Carolina-based company said it had a loss of 45 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The biopharmaceutical company posted revenue of $46,000 in the period.

For the year, the company reported that its loss widened to $173.2 million, or $2.04 per share. Revenue was reported as $2 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CMRX at